These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 25694319)

  • 1. Health economics in clinical research.
    Manns BJ
    Methods Mol Biol; 2015; 1281():315-30. PubMed ID: 25694319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of health economics within clinical research.
    Manns BJ
    Methods Mol Biol; 2009; 473():235-50. PubMed ID: 19160742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence-Based Decision Making 7: Health Economics in Clinical Research.
    Manns BJ
    Methods Mol Biol; 2021; 2249():501-516. PubMed ID: 33871861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force.
    Goettsch WG; Enzing J
    Value Health; 2014; 17(1):1-2. PubMed ID: 24438710
    [No Abstract]   [Full Text] [Related]  

  • 5. Health economics in drug development: efficient research to inform healthcare funding decisions.
    Hall PS; McCabe C; Brown JM; Cameron DA
    Eur J Cancer; 2010 Oct; 46(15):2674-80. PubMed ID: 20655197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conducting clinical trials-costs, impacts, and the value of clinical trials networks: A scoping review.
    Bentley C; Cressman S; van der Hoek K; Arts K; Dancey J; Peacock S
    Clin Trials; 2019 Apr; 16(2):183-193. PubMed ID: 30628466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A changing medical and economic world: complex diseases and interest in economic evaluation of health technologies].
    Hiligsmann M; Reginster JY
    Rev Med Liege; 2012; 67(5-6):258-62. PubMed ID: 22891476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force.
    Husereau D; Drummond M; Petrou S; Carswell C; Moher D; Greenberg D; Augustovski F; Briggs AH; Mauskopf J; Loder E;
    Value Health; 2013; 16(2):231-50. PubMed ID: 23538175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic evaluation in critical care medicine.
    Cox HL; Laupland KB; Manns BJ
    J Crit Care; 2006 Jun; 21(2):117-24. PubMed ID: 16769454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions.
    Adang E; Voordijk L; Jan van der Wilt G; Ament A
    Health Policy; 2005 Oct; 74(2):146-56. PubMed ID: 16153475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Budgeting in health care systems.
    Maynard A
    Eff Health Care; 1984; 2(2):41-9. PubMed ID: 10269645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the anesthesiologist in the wider governance of healthcare and health economics.
    Martin J; Cheng D
    Can J Anaesth; 2013 Sep; 60(9):918-28. PubMed ID: 23820969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic evaluation in cardiology.
    Maniadakis N; Vardas P; Mantovani LG; Fattore G; Boriani G
    Europace; 2011 May; 13 Suppl 2():ii3-8. PubMed ID: 21518746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Which cancer clinical trials should be considered for economic evaluation? Selection criteria from the National Cancer Institute of Canada's Working Group on Economic Analysis.
    Evans WK; Coyle D; Gafni A; Walker H;
    Chronic Dis Can; 2003; 24(4):102-7. PubMed ID: 14733759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis.
    Mauskopf JA; Sullivan SD; Annemans L; Caro J; Mullins CD; Nuijten M; Orlewska E; Watkins J; Trueman P
    Value Health; 2007; 10(5):336-47. PubMed ID: 17888098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of economic methods used in complementary medicine.
    Doran CM; Chang DH; Kiat H; Bensoussan A
    J Altern Complement Med; 2010 May; 16(5):591-5. PubMed ID: 20804369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health economics in developing countries.
    Abel-Smith B
    J Trop Med Hyg; 1989 Aug; 92(4):229-41. PubMed ID: 2503621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How do we evaluate the economics of health care?
    Kumar S; Williams AC; Sandy JR
    Eur J Orthod; 2006 Dec; 28(6):513-9. PubMed ID: 17035484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force.
    Sullivan SD; Mauskopf JA; Augustovski F; Jaime Caro J; Lee KM; Minchin M; Orlewska E; Penna P; Rodriguez Barrios JM; Shau WY
    Value Health; 2014; 17(1):5-14. PubMed ID: 24438712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decision makers' views on health care objectives and budget constraints: results from a pilot study.
    Al MJ; Feenstra T; Brouwer WB
    Health Policy; 2004 Oct; 70(1):33-48. PubMed ID: 15312708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.